Revolutionary Technology Advances Diagnosis of Neurodegenerative Disorders: Bill Morice, M.D., Ph.D.
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Revolutionary Technology Advances Diagnosis of Neurodegenerative Disorders: Bill Morice, M.D., Ph.D.
-
Narrated by:
-
By:
About this listen
In this episode of “Answers From the Lab,” William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, is joined by Russ Lebovitz, M.D., Ph.D., CEO and co-founder of Amprion. They discuss their strategic collaboration and the innovative SAAmplify™–αSYN (CSF) test. They covered:
- Details about how the cerebrospinal fluid biomarker test (Mayo ID: ASYNC) benefits patients exhibiting signs and symptoms of clinically uncertain cognitive decline or clinically uncertain Parkinsonian syndromes.
- Groundbreaking science on proteins that Amprion leveraged to create a solution that meaningfully impacts patient care and provides value to clinicians.
- Information physicians receive from the test, and when they should consider ordering it for their patients.
- Opportunities to change diagnostic journeys by providing accurate, early diagnosis with SAAmplify–αSYN.
activate_mytile_page_redirect_t1
What listeners say about Revolutionary Technology Advances Diagnosis of Neurodegenerative Disorders: Bill Morice, M.D., Ph.D.
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.